Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Treatment Interruption”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00414518
What this trial is testing

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Who this might be right for
HIV Infections
University of Colorado, Denver 16
Early research (Phase 1)Active Not RecruitingNCT07053384
What this trial is testing

Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

Who this might be right for
HIV Infections
ViiV Healthcare 130
Not applicableStudy completedNCT00001899
What this trial is testing

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableStudy completedNCT00015704
What this trial is testing

Effect of Interleukin-2 on HIV Treatment Interruption

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT02614950
What this trial is testing

Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection

Who this might be right for
Acute HIV InfectionAntiretroviral Treatment Interruption
SEARCH Research Foundation 8
Testing effectiveness (Phase 2)Study completedNCT00056797
What this trial is testing

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Testing effectiveness (Phase 2)Study completedNCT00078442
What this trial is testing

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Testing effectiveness (Phase 2)Looking for participantsNCT05187429
What this trial is testing

Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy

Who this might be right for
HIV I Infection
University of Melbourne 42
Post-approval studies (Phase 4)Looking for participantsNCT07476339
What this trial is testing

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

Who this might be right for
HIV -1 InfectionHIV (Human Immunodeficiency Virus)HIV+1 more
CAN Community Health 200
Testing effectiveness (Phase 2)Study completedNCT02446847
What this trial is testing

3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

Who this might be right for
HIV-1 Infection
Rockefeller University 16
Not applicableStudy completedNCT03225118
What this trial is testing

Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 29
Not applicableStudy completedNCT04801758
What this trial is testing

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study

Who this might be right for
HIV Infection
HIV Vaccine Trials Network 18
Testing effectiveness (Phase 2)Study completedNCT00212888
What this trial is testing

Combination Vaccination Before HIV Treatment Interruption

Who this might be right for
HIV Infections
Ottawa Hospital Research Institute 52
Testing effectiveness (Phase 2)Ended earlyNCT06032546
What this trial is testing

Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

Who this might be right for
Human Immuno-deficiency Virus (HIV) Disease
AbbVie 163
Testing effectiveness (Phase 2)UnknownNCT03577782
What this trial is testing

Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy

Who this might be right for
HIV Infections
Hospitales Universitarios Virgen del Rocío 12
Not applicableStudy completedNCT04860323
What this trial is testing

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study

Who this might be right for
HIV Infection
HIV Vaccine Trials Network 13
Not applicableUnknownNCT05540964
What this trial is testing

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

Who this might be right for
HIV
American Gene Technologies International Inc. 7
Not applicableStudy completedNCT00050284
What this trial is testing

Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 158
Not applicableStudy completedNCT00918840
What this trial is testing

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

Who this might be right for
HIV Infection
Genetic Immunity 16
Large-scale testing (Phase 3)Study completedNCT00118677
What this trial is testing

Long-Term Supervised Treatment Interruption in HIV-Infected Patients

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Next Page